Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, September 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

blogs: 1 blog
policy: 1 policy source

twitter: 1 X user
patent: 27 patents

Citations

dimensions_citation: 813 Dimensions

Readers on

mendeley: 461 Mendeley

So far, Altmetric has seen 27 patents that reference this research output.

Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

About this Attention Score

Mentioned by

Citations

Readers on

Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the…

Grant US-11951190-B2

United States of America

Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the…

Grant US-11931430-B2

United States of America

Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy

Grant US-11911488-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-11717514-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-11369590-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-11318121-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-11298341-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-11155800-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-11083710-B2

United States of America

Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the…

Grant US-11045564-B2

United States of America

Double-labeled probe for molecular imaging and use thereof

Grant US-11020493-B2

United States of America

Conjugates for treating diseases caused by PSMA expressing cells

Grant US-10912840-B2

United States of America

Conjugates for imaging

Grant US-10898596-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-10828282-B2

United States of America

Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy

Grant US-10736974-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-10646581-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-10624971-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-10624969-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-10624970-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-10557128-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-10517957-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-10517956-B2

United States of America

PSMA binding ligand-linker conjugates and methods for using

Grant US-10485878-B2

United States of America

Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging…

Grant US-10471160-B2

United States of America

Double-labeled probe for molecular imaging and use thereof

Application US-10406246-B2

United States of America